WO2005046358A1 - オリーブまんでがん利用法および抗ピロリ菌活性を有する食品 - Google Patents
オリーブまんでがん利用法および抗ピロリ菌活性を有する食品 Download PDFInfo
- Publication number
- WO2005046358A1 WO2005046358A1 PCT/JP2004/016733 JP2004016733W WO2005046358A1 WO 2005046358 A1 WO2005046358 A1 WO 2005046358A1 JP 2004016733 W JP2004016733 W JP 2004016733W WO 2005046358 A1 WO2005046358 A1 WO 2005046358A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- olive
- food
- water
- hydrophilic natural
- helicobacter pylori
- Prior art date
Links
- 240000007817 Olea europaea Species 0.000 title claims abstract description 75
- 230000000694 effects Effects 0.000 title claims abstract description 55
- 235000013305 food Nutrition 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims abstract description 36
- 229940037467 helicobacter pylori Drugs 0.000 title claims abstract description 24
- 241000590002 Helicobacter pylori Species 0.000 title abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 78
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 40
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 38
- 239000000463 material Substances 0.000 claims abstract description 28
- 239000000284 extract Substances 0.000 claims abstract description 27
- 239000004006 olive oil Substances 0.000 claims abstract description 19
- 235000008390 olive oil Nutrition 0.000 claims abstract description 19
- 239000012141 concentrate Substances 0.000 claims abstract description 18
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 16
- 238000012545 processing Methods 0.000 claims abstract description 7
- 239000003921 oil Substances 0.000 claims description 31
- 235000019198 oils Nutrition 0.000 claims description 31
- 235000015203 fruit juice Nutrition 0.000 claims description 18
- 206010028980 Neoplasm Diseases 0.000 claims description 15
- 239000004480 active ingredient Substances 0.000 claims description 14
- 201000011510 cancer Diseases 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 12
- 239000004615 ingredient Substances 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 7
- 239000002351 wastewater Substances 0.000 claims description 5
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 125000004402 polyphenol group Chemical group 0.000 claims 2
- 230000001771 impaired effect Effects 0.000 claims 1
- 239000002699 waste material Substances 0.000 abstract description 15
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 14
- 238000003825 pressing Methods 0.000 abstract description 5
- 239000008346 aqueous phase Substances 0.000 abstract 3
- 239000007858 starting material Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 235000008504 concentrate Nutrition 0.000 description 16
- 239000000203 mixture Substances 0.000 description 14
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 239000007787 solid Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 230000012010 growth Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000008029 eradication Effects 0.000 description 5
- 229940095066 hydroxytyrosol Drugs 0.000 description 5
- 235000003248 hydroxytyrosol Nutrition 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 238000013138 pruning Methods 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000014510 cooky Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000589562 Brucella Species 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 229940068517 fruit extracts Drugs 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 229940114496 olive leaf extract Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 206010031009 Oral pain Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- HJLSLZFTEKNLFI-UHFFFAOYSA-N Tinidazole Chemical compound CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O HJLSLZFTEKNLFI-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- GGNQRNBDZQJCCN-UHFFFAOYSA-N benzene-1,2,4-triol Chemical compound OC1=CC=C(O)C(O)=C1 GGNQRNBDZQJCCN-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960002626 clarithromycin Drugs 0.000 description 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000021038 drupes Nutrition 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- -1 for example Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 229940079905 intestinal adsorbents bismuth preparations Drugs 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229960005053 tinidazole Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000004565 tumor cell growth Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/03—Products from fruits or vegetables; Preparation or treatment thereof consisting of whole pieces or fragments without mashing the original pieces
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/03—Products from fruits or vegetables; Preparation or treatment thereof consisting of whole pieces or fragments without mashing the original pieces
- A23L19/07—Fruit waste products, e.g. from citrus peel or seeds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a method of using cancer (whole).
- the present invention relates to a method for effectively utilizing oil extraction wastewater (Vegetation Water) derived from fruit juice produced in a process for producing olive oil, a method for effectively utilizing leaves generated by frequent pruning, and a method obtained by those methods.
- the present invention relates to a food having anti-Helicobacter pylori activity using the obtained food material as a raw material.
- H. pylori is a gram-negative short-rod bacterium that grows under microaerobic conditions, but produces urea-ammonia. It is acid resistant and inhabits the stomach and other anguish systems.
- Helicobacter pylori which produces pathogenic factors such as heat shock protein, air toxin, and mucinase in addition to perylase, is deeply involved in gastrointestinal diseases such as gastritis, gastric ulcer, duodenal ulcer, and gastric cancer. It is known. Therefore, as one of the means for preventing or treating these diseases, there is eradication of H. pylori which causes the disease.
- Conventional eradication methods include treatments using antibiotics such as tetracycline, amoxicillin, and clarithromycin, insect repellents such as metro-dazole and tinidazole, bismuth preparations, and drugs such as proton bomb inhibitors.
- antibiotics such as tetracycline, amoxicillin, and clarithromycin
- insect repellents such as metro-dazole and tinidazole
- bismuth preparations such as proton bomb inhibitors.
- drugs such as proton bomb inhibitors.
- problems such as side effects such as abdominal pain, diarrhea, and mucosal damage, and the occurrence of resistant bacteria, and only temporary administration is performed on the human body.
- Patent Document 1 JP 2001-181197 A Patent Document 2: JP-A-2002-10753
- the present invention aims at utilizing cancer (whole) by enclosing a plant called olive, that is, by using an unused portion of a plant to discard as little as possible.
- An object of the present invention is to provide a method for effectively utilizing oil extraction waste liquid (vegetation water) derived from fruit juice produced in a process for producing olive oil.
- Another object of the present invention is to provide a method for effectively utilizing olive leaves generated by frequent pruning.
- An object of the present invention is to provide a natural component having an anti-H. Pylori activity which can be taken in a constant manner, and a natural composition having the anti-H. Pylori activity using the component as an active ingredient.
- Another object of the present invention is to provide a food ingredient comprising a natural ingredient having anti-H. Pylori activity which can be ingested constantly and having anti-Helicobacter pylori activity using the food ingredient as a raw material.
- the present inventors have studied oil extraction wastewater (Vegetation Water) produced in the production process of olive oil, an extract of olive fruit, an extract of leaves, and an Oryu mouth which is a component of these. Pain and hydroxytyrosol were found to have excellent antibacterial properties against H. pylori.
- oil extraction waste water (Vegetation Water). It contains.
- the composition extracted with water, alcohol or a mixture thereof, and the composition extracted with water or alcohol or a mixture thereof are also polyphenol components derived from fruits. It contains. This poly The composition containing the phenol component has an excellent inhibitory effect on H. pylori.
- the gist of the present invention is the cancer utilization method in the following (1) to (3).
- hydrophilic natural component As the hydrophilic natural component, after the olive fruit containing the hydrophilic natural component is crushed, squeezed and Z or centrifuged to obtain juice water, olive fruit and Z or leaf extract, or the like.
- Olive Munch uses cancer, which uses water, olive fruits and extracts of Z or leaves, or their concentrates, as a material with anti-Helicobacter pylori activity.
- hydrophilic natural components derived from olive plants, more specifically, polyphenol components, preferably containing the hydrophilic natural components (Vegetation Water), An olive bean cancer method using olive fruit and Z or leaf extracts, or their concentrates, as a material with anti-Helicobacter pylori activity.
- the gist of the present invention is a food having the following anti-helicobacter pylori activity (6) to (9).
- (6) TOo having anti-Helicobacter pylori activity which is a food made from the food material produced by the method described in (5) above and which comprises a hydrophilic natural ingredient derived from an olive plant as an active ingredient.
- Vegetation Water derived from water more specifically, juice water produced during the production process of olive oil, extracts of olive fruit and Z or leaf, or their concentrates are used as anti-Helicobacter pylori activities Olive mandarin which is used as a food material having the following characteristics: Food produced from the food material manufactured by the Cancer Utilization Method as a raw material, and having anti-Helicobacter pylori activity containing a hydrophilic natural component derived from an olive plant as an active ingredient. Food with.
- a food having anti-Helicobacter pylori activity which is obtained by processing an olive plant so that a hydrophilic natural ingredient as an active ingredient is not damaged.
- the juice water derived from Olive or the concentrate thereof has excellent anti-H. Pylori activity, and thus is a food material having an anti-H. Pylori function, Olive fruit is crushed and then crushed and squeezed and Z or centrifuged to obtain juice water, olive fruit and Z or leaf extracts, or digested food by ingesting processed foods derived from these concentrates. It is possible to reduce H. pylori present in the organ system and reduce the risk of various diseases.
- the present invention also relates to olive leaf extract which is generated in large amounts by frequent pruning. However, it can provide one of the means for effectively utilizing as a material having anti-H. Pylori activity.
- Olive Olea europaea L.
- Olive is an evergreen tree belonging to the genus Olive in the Moxaceae family. It is said to be native to West Asia and is cultivated around the world, especially on the Mediterranean coast. It is said that there are more than 500 kinds of them, and they vary in cultivation suitability, fruit size, shape, oil content, and so on. Although the fruits are drupes, some varieties accumulate oil in the pulp (mesocarp) and have an oil content of more than 20%.
- Fruit is used not only for collecting oil but also for kakunae.
- the fruit itself exhibits a strong astringency. This is due to the high content of polyphenol components in olive fruits.
- the water content is approximately 50-70% by weight. This fruit is crushed into a whole, and further subjected to additional water depending on the oil extraction process, and then centrifuged or pressed through a stirring stage to extract oil. Is performed.
- the oil that can be harvested is approximately 10-25% by weight of the raw fruit, and the rest produces solids composed of insoluble components such as juice water, fiber, and protein.
- Juice water contains water-soluble components derived from olive fruits, and also includes active ingredients such as polyphenol components.
- the inventors of the present invention have demonstrated that all natural ingredients derived from olive and are often ingested as foods for a long time and have extremely high safety for the human body.
- the present inventors have found that they have an excellent inhibitory action on bacteria, and have reached the present invention.
- natural water derived from olive, particularly fruit juice water comprising a hydrophilic component, etc. contains a high concentration of an anti-H. Pylori active component represented by a polyphenol component.
- hydroxyurethanol (3,4-dihydroxyphenol), which is a kind of glycoside, ore mouth pain didiphenol compound, is a porifenol component characteristic of olive.
- the polyphenol component is present in high concentrations in juice water and fruit extracts, all of which exhibit strong anti-H. Pylori activity.
- the composition extracted with leaf power water or alcohol contains a polyphenol component similarly to fruit.
- the hydrophilic natural component having anti-Helicobacter pylori activity of the present invention is obtained by crushing olive fruits containing the hydrophilic natural component, and then pressing and Z or centrifuging to obtain juice water. , Olive fruit and z or leaf extracts, or concentrates thereof. That is, the anti-H. Pylori activity is exerted by a method using juice water containing these components or a concentrate thereof as an active ingredient.
- the water content of olive-derived juice can be obtained by crushing the olive fruit and pressing and Z or centrifuging, or extracting the olive fruit with water or alcohol.
- Leaf strength The composition extracted with water or alcohol contains a polyphenol component as well as the fruit, and the fruit may contain leaves if necessary.
- the juice water produced in the production process of olive oil is an unnecessary product in the present process for the purpose of extracting only the olive oil, and is currently treated as waste!
- the present invention relates to a water extract of a juice, for example, an oil-derived waste liquid derived from a juice produced during production of olive oil (
- Vegetation Water as one of the means for effectively utilizing H. pylori as a material having anti-H. Pylori activity.
- leaves and branches are a large amount of waste, and the leaves and branches are extracted with water or alcohol and concentrated to have components and effects almost equivalent to those of juice juice.
- An extract can be obtained. This can also be used as a material having anti-H. Pylori activity.
- the solid matter (oil residue) generated at the time of oil harvesting and the leaves generated by pruning are currently discarded, but can be effectively used together with the oil waste liquid.
- Fruit juice water can be concentrated and used in order to facilitate its use in processing into foods and the like and to increase the concentration of active ingredients.
- Concentration under reduced pressure or membrane concentration may be used to prevent loss.
- the concentrated liquid can be further concentrated to a solid.
- Leaf extracted with water or alcohol can also be used in the same manner as juice water, because it has almost the same components and effects as juice water when concentrated.
- the food having an anti-H. Pylori activity in the present invention is a food containing an anti-H. Pylori active natural ingredient derived from Olive, fruit juice water or concentrate containing the natural ingredient as an active ingredient, and fruit Or a food containing one or more leaf extracts.
- the foods include foods obtained from raw olive plants prepared by kneading so that the hydrophilic natural ingredient as an active ingredient is not damaged. That is, any form of food can be used as long as the results of the latest scientific research by the present inventors on natural components derived from olive can be provided in safe and natural foods.
- the health food may be a readily available form such as a power capsule or a tablet manufactured from olive drink and olive cookie.
- the contents in the form of a capsule, can be protected, such as by oxidizing them, immediately before ingestion, so that the contents can be carried as much as needed, or the capsule can be removed and taken directly into water when actually ingesting. It is also possible to take only the contents, such as by taking a solution. Foods that use "fruit” itself as a processing raw material with astringency, and “leaves” as a processing raw material in the form of a paste as it is, are also possible.
- the waste oil produced in the olive oil production process was centrifuged at 3000 rpm for 5 minutes to obtain a supernatant. This was filtered through filter paper to obtain fruit juice water.
- Olive fruits or leaves were crushed with 100 ml of water or an 80% by volume ethanol solution to 100 g of water and crushed, followed by shaking extraction. Filtered after extraction and the same as added earlier to the residue Water or an 80% by volume ethanol solution was dried, filtered in the same manner, and the filtrate was combined to obtain an extract. The extract was concentrated under reduced pressure at a temperature of 45 ° C. or less to obtain a solid content.
- Antibacterial tests using a solid plate medium were performed on the water content and extract of the juice obtained in Examples 1 and 2 above, and on Oryu mouth pane and hydroxytyrosol.
- Example 1 The juice water obtained in Example 1 and the extract obtained in Example 2 were redissolved in distilled water, and the supernatant obtained by centrifuging this solution at 3,000 rpm for 5 minutes was added. The solution was sterilized by filtration and used as a test solution. For Oryu mouth pane and hydroxytyrosol, each substance was dissolved in distilled water and filtered and sterilized to obtain a test solution.
- Helicobacter pylori (ATCC43504) was used as a standard strain. This strain was inoculated into Brucella liquid medium containing 7% by volume of horse serum, cultured at 37 ° C under microaerobic conditions, and the culture was diluted to obtain a test bacterial solution.
- Brucella agar containing a fixed amount of test solution and 7% by volume of horse serum was plated on a sterile petri dish.
- the bacterial solution for testing was applied to this plate, cultured under microaerobic conditions at 37 ° C, and the antibacterial activity was calculated from the number of colonies of the bacteria that grew.
- the juice water is concentrated under reduced pressure and concentrated to a solid content to obtain a juice water concentrate.
- the juice water produced in the production process of olive oil is an unnecessary product in the present process for the purpose of collecting only the olive oil, and is currently treated as waste! / You.
- the present invention has a possibility of providing one of means for effectively utilizing juice water, for example, oil extraction waste liquid (Vegetation Water) generated during production of olive oil as a material having anti-H. Pylori activity.
- Oil extraction waste liquid Vetation Water
- the present invention relates to a method for effectively utilizing oil refining slag, which is a solid component produced together with the oil refining effluent in the process of producing olive oil, with water, alcohol or a mixture thereof and concentrating it as a material having anti-H. Pylori activity. There is a possibility to provide one.
- the present invention has the potential to provide one of the means for effectively utilizing olive leaves extracted with water, alcohol or a mixture thereof and concentrating them as a material having anti-H. Pylori activity.
- the consumption of processed foods with anti-H. Pylori activity which can be ingested regularly, using oil-derived wastewater, juice extract, and concentrates of Z or leaf extract derived from fruit juice as food materials. It may reduce the number of H. pylori present in the dungeon system and reduce the risk of various diseases.
- the present invention has the potential to promote the development of foods having anti-H. Pylori activity, which are obtained by processing cancers of olive plant flour so that the hydrophilic natural components as active ingredients are not damaged. .
- 1 is a drawing for explaining the effect of olive on the suppression of H. pylori by water content of fruit juice.
- Fig. 2 is a drawing for explaining the inhibitory effect of the extract of olive fruits or leaves on H. pylori.
- Fig. 3 is a drawing illustrating the effect of H. pylori on the inhibition of H. pylori.
- FIG. 4 is a drawing illustrating the effect of hydroxytyrosol on suppressing H. pylori.
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-385832 | 2003-11-14 | ||
JP2003385832A JP3858054B2 (ja) | 2003-11-14 | 2003-11-14 | オリーブまんでがん利用法および抗ピロリ菌活性を有する食品 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005046358A1 true WO2005046358A1 (ja) | 2005-05-26 |
Family
ID=34587379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/016733 WO2005046358A1 (ja) | 2003-11-14 | 2004-11-11 | オリーブまんでがん利用法および抗ピロリ菌活性を有する食品 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP3858054B2 (ja) |
WO (1) | WO2005046358A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2393901A1 (es) * | 2011-03-28 | 2012-12-28 | Oleapure, S.L. | Nuevo proceso de obtención de aceite de oliva. |
CN107090430A (zh) * | 2017-03-27 | 2017-08-25 | 山西医科大学 | 一种裂环烯醚萜苷类复合物的制备及其提高骨髓间充质干细胞活力的应用 |
WO2018189730A1 (en) * | 2017-04-14 | 2018-10-18 | Levius Vita Foods S.R.L. | A method and an apparatus for preparing a high-polyphenols olive oil |
WO2020165747A1 (fr) * | 2019-02-12 | 2020-08-20 | THUELER, Fabrice | Eau végétale |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8197862B2 (en) * | 2007-08-21 | 2012-06-12 | Dsm Ip Assets B.V. | Method of making distilled olive juice extracts |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001252054A (ja) * | 2000-01-07 | 2001-09-18 | Kanebo Ltd | 食品組成物 |
JP2002186453A (ja) * | 1999-10-14 | 2002-07-02 | Nisshin Oil Mills Ltd:The | オリーブ抽出物を含有してなる飲食物 |
JP2002205031A (ja) * | 2001-01-11 | 2002-07-23 | Masamichi Takahashi | 産業廃棄物である、オリーブ搾油粕、及び搾油廃液処理と、それに伴う再利用物質の採取 |
JP2002322079A (ja) * | 2001-04-25 | 2002-11-08 | Bunshi Eiyogaku Kenkyusho:Kk | ピロリ菌除菌組成物及びピロリ菌抗菌、除菌剤 |
JP2004161676A (ja) * | 2002-11-13 | 2004-06-10 | Kinka:Kk | 抗菌剤およびその製造方法 |
-
2003
- 2003-11-14 JP JP2003385832A patent/JP3858054B2/ja not_active Expired - Fee Related
-
2004
- 2004-11-11 WO PCT/JP2004/016733 patent/WO2005046358A1/ja active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002186453A (ja) * | 1999-10-14 | 2002-07-02 | Nisshin Oil Mills Ltd:The | オリーブ抽出物を含有してなる飲食物 |
JP2001252054A (ja) * | 2000-01-07 | 2001-09-18 | Kanebo Ltd | 食品組成物 |
JP2002205031A (ja) * | 2001-01-11 | 2002-07-23 | Masamichi Takahashi | 産業廃棄物である、オリーブ搾油粕、及び搾油廃液処理と、それに伴う再利用物質の採取 |
JP2002322079A (ja) * | 2001-04-25 | 2002-11-08 | Bunshi Eiyogaku Kenkyusho:Kk | ピロリ菌除菌組成物及びピロリ菌抗菌、除菌剤 |
JP2004161676A (ja) * | 2002-11-13 | 2004-06-10 | Kinka:Kk | 抗菌剤およびその製造方法 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2393901A1 (es) * | 2011-03-28 | 2012-12-28 | Oleapure, S.L. | Nuevo proceso de obtención de aceite de oliva. |
CN107090430A (zh) * | 2017-03-27 | 2017-08-25 | 山西医科大学 | 一种裂环烯醚萜苷类复合物的制备及其提高骨髓间充质干细胞活力的应用 |
CN107090430B (zh) * | 2017-03-27 | 2021-03-23 | 山西医科大学 | 一种裂环烯醚萜苷类复合物的制备及其提高骨髓间充质干细胞活力的应用 |
WO2018189730A1 (en) * | 2017-04-14 | 2018-10-18 | Levius Vita Foods S.R.L. | A method and an apparatus for preparing a high-polyphenols olive oil |
CN110799040A (zh) * | 2017-04-14 | 2020-02-14 | 莱维斯维塔食品公司 | 一种用于制备高多酚橄榄油的方法和设备 |
US11912957B2 (en) | 2017-04-14 | 2024-02-27 | Levius Vita Foods S.R.L. | Method and an apparatus for preparing a high-polyphenols olive oil |
WO2020165747A1 (fr) * | 2019-02-12 | 2020-08-20 | THUELER, Fabrice | Eau végétale |
Also Published As
Publication number | Publication date |
---|---|
JP3858054B2 (ja) | 2006-12-13 |
JP2005143398A (ja) | 2005-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Campos et al. | What is the future of Bee-Pollen | |
US7329421B2 (en) | Process of manufacturing clear juice from the leaves of the Aloe vera plant | |
JP4393777B2 (ja) | 抗ヘリコバクター・ピロリ用組成物 | |
KR20150098525A (ko) | 숙취해소 및 간 보호기능 개선용 건강기능성 조성물, 이를 포함하는 건강기능성 식품 및 식품첨가제 | |
KR101377586B1 (ko) | 고상 발효에 의한 항산화 활성 및 총 페놀 화합물 함량이 증진된 차가버섯 발효물의 제조방법 | |
KR101324733B1 (ko) | 볏짚 추출물을 이용한 간 보호기능, 간질환 개선,항암,항균,이뇨,우유제품소화기능이 우수하며 이유식대용,구충,해독 및 발효효과가 있는 건강 환 및 그 제조방법 | |
CN101883574B (zh) | 牙周病菌增殖抑制剂、口腔卫生品及饮食品 | |
KR100894636B1 (ko) | 둥근마추출액을 함유한 음료의 제조방법 | |
JP3858054B2 (ja) | オリーブまんでがん利用法および抗ピロリ菌活性を有する食品 | |
Sharma et al. | Bioactive compounds present in different parts of Guava and their significance: A review | |
JP3441432B2 (ja) | 柑橘類搾汁副産物に含まれる有用成分の濃縮方法及びそれを含む栄養組成物 | |
Rana et al. | The Various Pharmacological Activity of Adansonia digitata | |
JP3762364B2 (ja) | ミミズと蟻を用いた健康食品の製造方法 | |
KR102202065B1 (ko) | 항균식물 복합 발효액을 이용한 고추장 제조방법 | |
JP4376512B2 (ja) | アンギオテンシン変換酵素阻害剤および抗高血圧食品 | |
RU2710261C1 (ru) | Способ комплексной переработки свежих плодов боярышника мягковатого | |
KR20170125191A (ko) | 아로니아 베리를 이용한 환 및 그의 제조방법 | |
CN102215852B (zh) | 抗幽门螺杆菌活性剂 | |
KR20040005351A (ko) | 어성초 발효액 및 그 제조방법 | |
US20080286413A1 (en) | Making Process of Extract Containing Ingredients of a Radish and a Pumpkin, and Making Process of Granules and Pills by Using the Extract | |
KR20090093619A (ko) | 오미자 추출물 및 복분자 추출물을 함유하는 항헬리코박터조성물 | |
KR100789399B1 (ko) | 다시마, 우뭇가사리 및 지누아리 추출물이 함유된건강음료 조성물 | |
CN109568413A (zh) | 一种青梅口腔喷雾剂及其制备方法 | |
Martín et al. | Potential applications of Moringa oleifera. A critical review | |
KR20080032805A (ko) | 산삼 배양근 분말이 함유된 건강보조식품의 제조 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |